Company intelligence / Profile preview

Tiangen Biotech

Ownership: Private
Development stage: Commercial

Overview

Tiangen Biotech is a leading Chinese biotechnology supplier specializing in nucleic acid extraction/purification kits, PCR/qPCR/NGS reagents, protein analysis tools, and related laboratory instrumentation. Their products are widely used in academic research labs, hospitals, diagnostic labs—including large-scale infectious disease testing—and biopharma R&D. They played a significant role during the COVID‑19 pandemic by supplying millions of virus detection reagent tests globally. They do not develop or commercialize therapeutic drugs themselves.

Therapeutic areas: OtherInfectious Diseases
Modalities: Nucleic acid extraction and purificationPCR/RT-PCR/qPCR reagentsNext-generation sequencing library prep kitsProtein detection reagents
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Tiangen Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tiangen Biotech.

Explore the full profile